Varian "inspires," rewrites software
Engineers at Varian Medical have crafted a radiation oncology management system designed to simplify and facilitate delivery of advanced radiation therapy for treating cancer. The product, called Inspiration, was the focus of the company's exhibit Oct.
Engineers at Varian Medical have crafted a radiation oncology management system designed to simplify and facilitate delivery of advanced radiation therapy for treating cancer. The product, called Inspiration, was the focus of the company's exhibit Oct. 19 at the ASTRO annual meeting. Inspiration links all clinical activities, from imaging to planning, simulating, verifying, and delivering treatments. It is based on a unified database and information management system to which all devices and processes are tied.
Varian also displayed a redesigned version of its VARiS Vision radiation oncology management software. Enhancements streamline and accelerate processes involved in treating cancer with radiation therapy. The software simplifies the many steps involved in delivering a multiweek course of radiation therapy, including treatment planning, simulation, and scheduling.
Amid the technology and glitz of ASTRO, Varian executives heaped good financial news on shareholders, announcing their expectation that earnings in the fourth quarter of fiscal 2003 would rise by 26% to 27% over the year-earlier period. Net orders were expected to be 10% higher.
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.
SNMMI: Botox May Facilitate Relief from Dry Mouth Side Effect of PSMA-Targeted Radiopharmaceuticals
June 25th 2025For patients being treated with radiopharmaceutical agents for metastatic prostate cancer, the combination of botulinum toxin and an anti-nausea patch led to a 30 percent reduction in PSMA uptake in the salivary glands, according to preliminary research findings presented at the SNMMI conference.
